
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
Keisuke Kataoka, Hiroaki Miyoshi, Seiji Sakata, et al.
Leukemia (2019) Vol. 33, Iss. 7, pp. 1687-1699
Open Access | Times Cited: 126
Keisuke Kataoka, Hiroaki Miyoshi, Seiji Sakata, et al.
Leukemia (2019) Vol. 33, Iss. 7, pp. 1687-1699
Open Access | Times Cited: 126
Showing 1-25 of 126 citing articles:
Epstein-Barr virus: Biology and clinical disease
Blossom Damania, Shannon C. Kenney, Nancy Raab‐Traub
Cell (2022) Vol. 185, Iss. 20, pp. 3652-3670
Open Access | Times Cited: 231
Blossom Damania, Shannon C. Kenney, Nancy Raab‐Traub
Cell (2022) Vol. 185, Iss. 20, pp. 3652-3670
Open Access | Times Cited: 231
Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
Wyndham H. Wilson, George W. Wright, Da Wei Huang, et al.
Cancer Cell (2021) Vol. 39, Iss. 12, pp. 1643-1653.e3
Open Access | Times Cited: 221
Wyndham H. Wilson, George W. Wright, Da Wei Huang, et al.
Cancer Cell (2021) Vol. 39, Iss. 12, pp. 1643-1653.e3
Open Access | Times Cited: 221
Genomic profiling for clinical decision making in lymphoid neoplasms
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 107
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 107
Advances in understanding of angioimmunoblastic T-cell lymphoma
Shigeru Chiba, Mamiko Sakata‐Yanagimoto
Leukemia (2020) Vol. 34, Iss. 10, pp. 2592-2606
Open Access | Times Cited: 131
Shigeru Chiba, Mamiko Sakata‐Yanagimoto
Leukemia (2020) Vol. 34, Iss. 10, pp. 2592-2606
Open Access | Times Cited: 131
Targeting immune checkpoints in hematological malignancies
Basit Salik, Mark J. Smyth, Kyohei Nakamura
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 106
Basit Salik, Mark J. Smyth, Kyohei Nakamura
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 106
Mutational landscape of gray zone lymphoma
Clémentine Sarkozy, Stacy Hung, Elizabeth A. Chavez, et al.
Blood (2020) Vol. 137, Iss. 13, pp. 1765-1776
Open Access | Times Cited: 86
Clémentine Sarkozy, Stacy Hung, Elizabeth A. Chavez, et al.
Blood (2020) Vol. 137, Iss. 13, pp. 1765-1776
Open Access | Times Cited: 86
Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape
Jeff Bruce, Ka–Fai To, Vivian Wai Yan Lui, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 83
Jeff Bruce, Ka–Fai To, Vivian Wai Yan Lui, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 83
EBV-associated diseases: Current therapeutics and emerging technologies
Srishti Chakravorty, Behdad Afzali, Majid Kazemian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Srishti Chakravorty, Behdad Afzali, Majid Kazemian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Molecular profiling of EBV associated diffuse large B-cell lymphoma
Fabian Frontzek, Annette M. Staiger, Ramona Wullenkord, et al.
Leukemia (2023) Vol. 37, Iss. 3, pp. 670-679
Open Access | Times Cited: 35
Fabian Frontzek, Annette M. Staiger, Ramona Wullenkord, et al.
Leukemia (2023) Vol. 37, Iss. 3, pp. 670-679
Open Access | Times Cited: 35
The Immunology of DLBCL
Taishi Takahara, Shigeo Nakamura, Toyonori Tsuzuki, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 835-835
Open Access | Times Cited: 33
Taishi Takahara, Shigeo Nakamura, Toyonori Tsuzuki, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 835-835
Open Access | Times Cited: 33
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus
Kathryn Lurain, Ramya Ramaswami, Laurie T. Krug, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 10
Kathryn Lurain, Ramya Ramaswami, Laurie T. Krug, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 10
MYD88 in the driver’s seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications
Ruben A. L. de Groen, Anne M.R. Schrader, Marie José Kersten, et al.
Haematologica (2019) Vol. 104, Iss. 12, pp. 2337-2348
Open Access | Times Cited: 70
Ruben A. L. de Groen, Anne M.R. Schrader, Marie José Kersten, et al.
Haematologica (2019) Vol. 104, Iss. 12, pp. 2337-2348
Open Access | Times Cited: 70
Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma
Kazuyuki Shimada, Kenichi Yoshida, Yasuhíro Suzuki, et al.
Blood (2020) Vol. 137, Iss. 11, pp. 1491-1502
Open Access | Times Cited: 66
Kazuyuki Shimada, Kenichi Yoshida, Yasuhíro Suzuki, et al.
Blood (2020) Vol. 137, Iss. 11, pp. 1491-1502
Open Access | Times Cited: 66
EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2
Alexandre S. Cristino, Jamie P. Nourse, Rachael A. West, et al.
Blood (2019) Vol. 134, Iss. 25, pp. 2261-2270
Open Access | Times Cited: 55
Alexandre S. Cristino, Jamie P. Nourse, Rachael A. West, et al.
Blood (2019) Vol. 134, Iss. 25, pp. 2261-2270
Open Access | Times Cited: 55
Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
Marcus Bauer, Simon Jasinski‐Bergner, Ofer Mandelboim, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5189-5189
Open Access | Times Cited: 53
Marcus Bauer, Simon Jasinski‐Bergner, Ofer Mandelboim, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5189-5189
Open Access | Times Cited: 53
Immune checkpoint inhibitors in lymphoma: challenges and opportunities
Haris Hatic, Devi Sampat, Gaurav Goyal
Annals of Translational Medicine (2021) Vol. 9, Iss. 12, pp. 1037-1037
Open Access | Times Cited: 51
Haris Hatic, Devi Sampat, Gaurav Goyal
Annals of Translational Medicine (2021) Vol. 9, Iss. 12, pp. 1037-1037
Open Access | Times Cited: 51
miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer
Christos Miliotis, Frank J. Slack
Cancer Letters (2021) Vol. 518, pp. 115-126
Open Access | Times Cited: 47
Christos Miliotis, Frank J. Slack
Cancer Letters (2021) Vol. 518, pp. 115-126
Open Access | Times Cited: 47
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified
Estelle Bourbon, Delphine Maucort‐Boulch, Juliette Fontaine, et al.
Blood Advances (2021) Vol. 5, Iss. 16, pp. 3227-3239
Open Access | Times Cited: 46
Estelle Bourbon, Delphine Maucort‐Boulch, Juliette Fontaine, et al.
Blood Advances (2021) Vol. 5, Iss. 16, pp. 3227-3239
Open Access | Times Cited: 46
Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing
Niklas Gebauer, Axel Künstner, Julius Ketzer, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 5
Open Access | Times Cited: 42
Niklas Gebauer, Axel Künstner, Julius Ketzer, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 5
Open Access | Times Cited: 42
EBV‐positive B‐cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency
Akira Satou, Shigeo Nakamura
Cancer Medicine (2021) Vol. 10, Iss. 19, pp. 6777-6785
Open Access | Times Cited: 37
Akira Satou, Shigeo Nakamura
Cancer Medicine (2021) Vol. 10, Iss. 19, pp. 6777-6785
Open Access | Times Cited: 37
Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
Amira Marouf, Sammara Chaubard, Raphaël Liévin, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access
Amira Marouf, Sammara Chaubard, Raphaël Liévin, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access
BSRF1 modulates IFN-β-mediated antiviral responses by inhibiting NF-κB activity via an IKK-dependent mechanism in Epstein-Barr virus infection
Shengwen Chen, Yangxi Deng, Chen Huang, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141600-141600
Closed Access
Shengwen Chen, Yangxi Deng, Chen Huang, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141600-141600
Closed Access
Clinical and therapeutic significance of genetic profiling in adult T-cell leukemia/lymphoma
Yasunori Kogure, Keisuke Kataoka
Leukemia Research (2025) Vol. 151, pp. 107676-107676
Closed Access
Yasunori Kogure, Keisuke Kataoka
Leukemia Research (2025) Vol. 151, pp. 107676-107676
Closed Access
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
High-accuracy Detection of PD-L1 3’-UTR Disruption by Immunohistochemistry and Fluorescence in Situ Hybridization on Formalin-fixed Paraffin-embedded Sections
Ayumi Fujimoto, Seiji Sakata, Keisuke Kataoka, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Ayumi Fujimoto, Seiji Sakata, Keisuke Kataoka, et al.
The American Journal of Surgical Pathology (2025)
Closed Access